User:Cody Couperus/Sandbox 1
From Proteopedia
(Difference between revisions)
												
			
			| Line 25: | Line 25: | ||
| Thrombin interacts with platelet membrane protein [http://www.ncbi.nlm.nih.gov/pubmed/14720584 GpIbα] and subsequently cleave protease activated receptor-1 (PAR1) causing a signaling cascade which leads to platelet [http://en.wikipedia.org/wiki/Platelet_alpha-granule α-granule] release and membrane flipping exposing the negatively charged [http://en.wikipedia.org/wiki/Phosphatidylserine phosphatidylserine]. The platelet alpha granules contain the physiologically relevant pool of FVa. <ref>Camire, R. M. (2010). Platelet factor V to the rescue. Blood, 115(4), 753-754. [http://bloodjournal.hematologylibrary.org/content/115/4/753.full DOI: 10.1182/blood-2009-11-252619]</ref> | Thrombin interacts with platelet membrane protein [http://www.ncbi.nlm.nih.gov/pubmed/14720584 GpIbα] and subsequently cleave protease activated receptor-1 (PAR1) causing a signaling cascade which leads to platelet [http://en.wikipedia.org/wiki/Platelet_alpha-granule α-granule] release and membrane flipping exposing the negatively charged [http://en.wikipedia.org/wiki/Phosphatidylserine phosphatidylserine]. The platelet alpha granules contain the physiologically relevant pool of FVa. <ref>Camire, R. M. (2010). Platelet factor V to the rescue. Blood, 115(4), 753-754. [http://bloodjournal.hematologylibrary.org/content/115/4/753.full DOI: 10.1182/blood-2009-11-252619]</ref> | ||
| - | Thrombin also causes activation of  | + | Thrombin also causes activation of FX, through [http://en.wikipedia.org/wiki/Factor_IX FIX] cleavage, and FVIII which form the Xase complex to activate FX. FVa and FXa form the [http://en.wikipedia.org/wiki/Prothrombinase prothrombinase] complex in the presence of calcium and phospholipid. It causes rapid activation of prothrombin to thrombin. This increase in thrombin allows sufficient fibrinogen to be cleaved to fibrin which is able to polymerize to form a stable [http://en.wikipedia.org/wiki/Thrombus blood clot].  | 
| Further supporting coagulation, thrombin activates FXIII, a [http://en.wikipedia.org/wiki/Transglutaminase transglutaminase] that crosslinks fibrin at lysine residues.  | Further supporting coagulation, thrombin activates FXIII, a [http://en.wikipedia.org/wiki/Transglutaminase transglutaminase] that crosslinks fibrin at lysine residues.  | ||
Revision as of 07:54, 30 April 2014
| 
 | |||||||||||
References
- ↑ Fenton JW 2nd. Thrombin specificity. Ann N Y Acad Sci. 1981;370:468-95. PMID:7023326
- ↑ 2.0 2.1 Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000 Sep 14;407(6801):258-64. PMID:11001069 doi:http://dx.doi.org/10.1038/35025229
- ↑ Crawley JT, Lam JK, Rance JB, Mollica LR, O'Donnell JS, Lane DA. Proteolytic inactivation of ADAMTS13 by thrombin and plasmin. Blood. 2005 Feb 1;105(3):1085-93. Epub 2004 Sep 23. PMID:15388580 doi:http://dx.doi.org/10.1182/blood-2004-03-1101
- ↑ 4.0 4.1 4.2 4.3 4.4 4.5 4.6 Lane DA, Philippou H, Huntington JA. Directing thrombin. Blood. 2005 Oct 15;106(8):2605-12. Epub 2005 Jun 30. PMID:15994286 doi:http://dx.doi.org/10.1182/blood-2005-04-1710
- ↑ Takagi T, Doolittle RF. Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin. Biochemistry. 1974 Feb 12;13(4):750-6. PMID:4811064
- ↑ Miljic P, Heylen E, Willemse J, Djordjevic V, Radojkovic D, Colovic M, Elezovic I, Hendriks D. Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis. Srp Arh Celok Lek. 2010 Jan;138 Suppl 1:74-8. PMID:20229688
- ↑ 7.0 7.1 7.2 7.3 Huntington JA. Natural inhibitors of thrombin. Thromb Haemost. 2014 Apr 1;111(4):583-9. doi: 10.1160/TH13-10-0811. Epub 2014 Jan, 30. PMID:24477356 doi:http://dx.doi.org/10.1160/TH13-10-0811
- ↑ 8.0 8.1 8.2 8.3 Huntington JA. Thrombin inhibition by the serpins. J Thromb Haemost. 2013 Jun;11 Suppl 1:254-64. doi: 10.1111/jth.12252. PMID:23809129 doi:http://dx.doi.org/10.1111/jth.12252
- ↑ Esmon CT. The regulation of natural anticoagulant pathways. Science. 1987 Mar 13;235(4794):1348-52. PMID:3029867
- ↑ Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem. 1994 Dec 16;269(50):31869-80. PMID:7989361
- ↑ 11.0 11.1 Lu D, Kalafatis M, Mann KG, Long GL. Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V. Blood. 1996 Jun 1;87(11):4708-17. PMID:8639840
- ↑ Duga S, Asselta R, Tenchini ML. Coagulation factor V. Int J Biochem Cell Biol. 2004 Aug;36(8):1393-9. PMID:15147718 doi:http://dx.doi.org/10.1016/j.biocel.2003.08.002
- ↑ Saenko EL, Shima M, Sarafanov AG. Role of activation of the coagulation factor VIII in interaction with vWf, phospholipid, and functioning within the factor Xase complex. Trends Cardiovasc Med. 1999 Oct;9(7):185-92. PMID:10881749
- ↑ Camire, R. M. (2010). Platelet factor V to the rescue. Blood, 115(4), 753-754. DOI: 10.1182/blood-2009-11-252619
- ↑ 15.0 15.1 15.2 15.3 15.4 15.5 15.6 15.7 Lechtenberg BC, Freund SM, Huntington JA. An ensemble view of thrombin allostery. Biol Chem. 2012 Sep;393(9):889-98. doi: 10.1515/hsz-2012-0178. PMID:22944689 doi:http://dx.doi.org/10.1515/hsz-2012-0178
- ↑ Tijburg PN, van Heerde WL, Leenhouts HM, Hessing M, Bouma BN, de Groot PG. Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation on endothelial cells. The influence of thrombin on the reaction mechanism. J Biol Chem. 1991 Feb 25;266(6):4017-22. PMID:1995649
- ↑ Bobofchak KM, Pineda AO, Mathews FS, Di Cera E. Energetic and structural consequences of perturbing Gly-193 in the oxyanion hole of serine proteases. J Biol Chem. 2005 Jul 8;280(27):25644-50. Epub 2005 May 12. PMID:15890651 doi:http://dx.doi.org/10.1074/jbc.M503499200
- ↑ 18.0 18.1 18.2 18.3 Bode W, Mayr I, Baumann U, Huber R, Stone SR, Hofsteenge J. The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J. 1989 Nov;8(11):3467-75. PMID:2583108
- ↑ Page MJ, Di Cera E. Evolution of peptidase diversity. J Biol Chem. 2008 Oct 31;283(44):30010-4. doi: 10.1074/jbc.M804650200. Epub 2008 , Sep 3. PMID:18768474 doi:http://dx.doi.org/10.1074/jbc.M804650200
- ↑ Schechter I, Berger A. On the size of the active site in proteases. I. Papain. 1967. Biochem Biophys Res Commun. 2012 Aug 31;425(3):497-502. doi:, 10.1016/j.bbrc.2012.08.015. PMID:22925665 doi:http://dx.doi.org/10.1016/j.bbrc.2012.08.015
- ↑ Huntington JA. Molecular recognition mechanisms of thrombin. J Thromb Haemost. 2005 Aug;3(8):1861-72. PMID:16102053 doi:http://dx.doi.org/10.1111/j.1538-7836.2005.01363.x
- ↑ Zhang E, Tulinsky A. The molecular environment of the Na+ binding site of thrombin. Biophys Chem. 1997 Jan 31;63(2-3):185-200. PMID:9108691




